Just in time for flu season, AstraZeneca granted Daiichi Sankyo an exclusive license to market its FluMist Quadrivalent in Japan. The live attenuated vaccine, delivered nasally, went through Phase III trials in Japanese children, and a regulatory submission is being prepared for Japan.
To get the word out on AstraZeneca's needle-free FluMist Quadrivalent vaccine, the company has brought on James Van Der Beek--of "Dawson's Creek" fame--to participate in its "Insist on the Mist" campaign.
AstraZeneca's flu vaccine sales may have just gotten a boost, courtesy of federal regulators. Wednesday, they recommended that healthy children 2 to 8 years old receive the company's nasal spray flu vaccine FluMist in lieu of flu shots when available.
When MedImmune won approval for its quadrivalent nasal flu vaccine back in February 2012, it kicked off the battle to claim a share of the next-generation influenza immunization market. Now, almost two years later, its parent company AstraZeneca has the race underway in Europe, too.
AstraZeneca ($AZN) snagged a contract in the U.K. that will make its Fluenz nasal spray the vaccine of choice for children ages two to 17.
Hemispherx Biopharma's RNA-based adjuvant, Ampligen (rintatolimod), is being tested in a new indication--this time intranasally for the first time in humans along with AstraZeneca's nasal flu vaccine FluMist.
The FDA has approved AstraZeneca's ($AZN) nasal FluMist Quadrivalent flu vaccine for use in people ages 2 to 49. Made at AstraZeneca's MedImmune unit, FluMist Quadrivalent contains two...
A study conducted by the Trudeau Institute finally demystifies how the nasal flu vaccine FluMist elicits protection. "Influenza infection normally induces a massive inflammatory response in the lungs
Flu vaccines would probably protect children better if they included both strains of influenza B instead of just one, Saint Louis University (SLU) researchers say. "Each year, the FDA selects two
Two new studies came out this week that could play a big role in shaping the market for seasonal flu vaccines. In the first, researchers found clear evidence that influenza is linked to a higher risk